Causeway Coffee launches the Espresso Direct IV
Apr 01, 2025
PRESS RELEASE
FOR IMMEDIATE RELEASE
BALLYMONEY, 1 APRIL 2025
Innovative speciality coffee company Causeway Coffee today releases details of its first foray into coffee hardware, with the startling Espresso Direct IV. The device combines elements of both the most advanced espresso technology ever seen with bleeding-edge medical and aerospace technology to inject precision-calibrated shots of espresso direct into a user’s bloodstream.
Chief Caffeine Officer Graham Watts commented:
“No longer will coffee connoisseurs spend long minutes in a cold sweat, craving their next shot. With the IV Espresso Direct, users can be assured of a steady drip of finest-quality artisan coffee, straight into their bloodstream.
The IV has triple, integral diamond-alloy blur grinders producing astonishingly tiny grains as small as 1.9 microns in diameter. This is of course far too fine for a conventional machine, however, repurposing fuel injectors from seventh-generation CFD turbofan aviation jet engines, we have been able to achieve a water pressure of over 250,000 bar at the machine’s jet head, powering straight through the nanofine coffee particles contained in 32 ultra-high-pressure extraction chambers, themselves based on deep-sea submarine technology.
RFID nanobots, injected with the intravenous espresso stream, continually monitor the user’s heart rate, blood pressure, pH, and alignment in four planes: vertical, latitudinal, longitudinal and reality. This is truly the first and finest automatic bean-to-blood apparatus available.”
The company is planning to demonstrate the Direct IV Espresso at the Milan International Pharmaceutical Fair on 23 June, and is already planning to build on the technology, with both a fixed version capable of injecting users with milky coffee drinks such as cappuccino and latte, and a portable and miniaturised version, the Caffeeman.
- ENDS -
